Cabazitaxel

SKU: orb1305338

Description

Cabazitaxel

Research Area

Cell Biology, Signal Transduction

Key Properties

• CAS Number: 183133-96-2
• MW: 835.93
• Purity: 99.72%
• Formula: C₄₅H₅₇NO₁₄
• SMILES: CO[C@H]1C[C@H]2OC[C@@]2(OC(C)=O)[C@H]2[C@H](OC(=O)c3ccccc3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)OC(C)(C)C)c4ccccc4)C(C)=C([C@@H](OC)C(=O)[C@]12C)C3(C)C
• Target: Microtubule Associated,Autophagy
• Solubility: H2O:< 1 mg/mL (insoluble or slightly soluble);10% DMSO+40% PEG300+5% Tween 80+45% Saline:3.3 mg/mL (3.95 mM);DMSO:240 mg/mL (287.11 mM);Ethanol:< 1 mg/mL (insoluble or slightly soluble)

Bioactivity

• In Vivo:
  Cabazitaxel has an average in vitro human plasma protein binding rate of 91.6%. It is rapidly and extensively metabolized into various metabolites. Cabazitaxel exhibits activity in multiple resistant cell lines in both mice and humans, and it increases the enzymatic activity of CYP3A in rat liver cells. Additionally, Cabazitaxel demonstrates high antitumor activity in three colon cancer cell lines (HCT-116, HCT-8, and HT-29). Treating with relatively low concentrations of Cabazitaxel for four days results in significant cytotoxicity.
• In Vitro:
  In situ and subcutaneous mouse xenografts were generated using SF-295 and U251 human glioblastoma cell lines. Treatment with Cabazitaxel resulted in the complete regression of the majority of subcutaneously implanted tumors. Cabazitaxel also demonstrated significant antitumor activity in other related models. Specifically, Cabazitaxel led to complete tumor regression in mouse tumor xenograft models (colon C38 and pancreatic P03). Moreover, in the in situ model, Cabazitaxel caused complete regression in 4 out of 10 U251 tumors.
• Cell Research:
  The cytotoxicity of CBX-loaded ANs and free Cabazitaxel (CBX) is evaluated with MTT assay. Cells are seeded onto a 96-well plate at a density of 3000 cells per well and cultured for 24 h. CBX-loaded ANs and free CBX are diluted to predetermined concentrations with PBS and added into each well. Blank AN, AN-ICG and free CBX solvent (a mixture of Tween-80 and anhydrous alcohol) are added as well to different final concentrations. The incubation continued for another 48 hours. 20 μL MTT solutions (5 mg/mL in PBS) are added into each well and cells are incubated for another 4 hours under 37°C. Subsequently the medium is removed and 150 μL dimethyl sulphoxide (DMSO) is added to dissolve the purple formazan salt crystals. Then the absorbance is measured by a microplate reader at 490 nm. The cells treated with medium are evaluated as controls.

Storage & Handling

• Storage: Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.
• Expiration Date: 12 months from date of receipt.
• Disclaimer: For research use only

Alternative Names

Autophagy, Cabazitaxel, Microtubule Associated, MicrotubuleAssociated, Microtubule/Tubulin, microtubule, inhibit, Inhibitor, taxoid XRP 6258, taxoid XRP6258, taxoid XRP-6258, RPR-116258A, XRP-6258, XRP6258, XRP 6258, TXD 258, TXD258, TXD-258

Compound Identifiers

PubChem CID

9854073